Covered recipient · General Payments record
CATHERINE ANN WRIGLEY
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2021–2024
$1,809.53
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $534.83 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $195.76 | 10 |
| Acerta Pharma LLC | $65.83 | 3 |
| ABBVIE INC. | $65.55 | 3 |
| Lilly USA, LLC | $49.59 | 3 |
| Genentech USA, Inc. | $35.57 | 2 |
| UCB, Inc. | $33.98 | 2 |
| Janssen Biotech, Inc. | $25.11 | 1 |
| Sandoz Inc. | $19.73 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.43 | 1 |
| Alexion Pharmaceuticals, Inc. | $15.04 | 1 |
| Organon LLC | $12.24 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.36 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103652610 | CMS |
| ABBVIE INC. | $22.67 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103652612 | CMS |
| ABBVIE INC. | $18.52 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103652614 | CMS |
| Alexion Pharmaceuticals, Inc. | $15.04 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094022427 | CMS |
| Amgen Inc. | $12.61 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111565257 | CMS |
| Amgen Inc. | $30.97 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111565259 | CMS |
| Amgen Inc. | $17.31 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111565253 | CMS |
| Amgen Inc. | $5.79 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111565249 | CMS |
| Amgen Inc. | $21.73 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111565255 | CMS |
| Amgen Inc. | $22.85 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240942 | CMS |
| Amgen Inc. | $30.30 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240936 | CMS |
| Amgen Inc. | $10.16 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111565251 | CMS |
| Amgen Inc. | $11.42 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240938 | CMS |
| Amgen Inc. | $32.62 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240940 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.82 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105233804 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.41 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105453419 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.60 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105741908 | CMS |
| Genentech USA, Inc. | $14.89 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132985207 | CMS |
| Genentech USA, Inc. | $20.68 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132985211 | CMS |
| Janssen Biotech, Inc. | $25.11 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078574302 | CMS |
| Lilly USA, LLC | $21.62 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136089124 | CMS |
| Lilly USA, LLC | $14.44 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136089378 | CMS |
| Lilly USA, LLC | $13.53 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136092006 | CMS |
| Novartis Pharmaceuticals Corporation | $16.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086853505 | CMS |
| Organon Llc | $6.38 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136310161 | CMS |
| Organon Llc | $5.86 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136310163 | CMS |
| Sandoz Inc. | $19.73 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089364411 | CMS |
| UCB, Inc. | $20.22 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143351746 | CMS |
| UCB, Inc. | $13.76 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143351750 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.